TISSUE REGENIX
Tissue Regenix commercializes innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. Tissue Regenix was founded in May 2006, to commercialize innovative technologies in regenerative medicine.
TISSUE REGENIX
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2006-05-01
Address:
York, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.tissueregenix.com
Total Employee:
51+
Status:
Active
Contact:
+44 1904 567609
Email Addresses:
[email protected]
Total Funding:
15.29 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Apache Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is LSE:TRX
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-07-21 | CellRight Technologies | CellRight Technologies acquired by Tissue Regenix | 30 M USD |
Investors List
Aquarius Equity Partners
Aquarius Equity Partners investment in Venture Round - Tissue Regenix
White Rose Technology Seedcorn Fund
White Rose Technology Seedcorn Fund investment in Venture Round - Tissue Regenix
IP Group
IP Group investment in Venture Round - Tissue Regenix
Official Site Inspections
http://www.tissueregenix.com
Unable to get host informations!!!
Loading ... 